OBJECTIVE: Telomeres are required for maintaining genomic integrity and may play a role in carcinogenesis. Some, but not all, epidemiologic studies have found that short telomeres in leukocytes are associated with an increased risk of breast cancer. To further elucidate this potential association, we examined telomere length in relation to breast cancer risk in prospectively collected blood samples from the Sister Study, a cohort of women aged 35-74 years who have a sister with breast cancer. METHODS: We performed a case-cohort analysis comparing incident breast cancer cases (n = 342) with a subcohort (n = 735), randomly selected from 29,026 participants, enrolled by June 1, 2007. Relative telomere length in peripheral blood cells was estimated using a single-tube monochrome multiplex quantitative PCR assay. RESULTS: No association was observed between telomere length and breast cancer risk. Compared with the longest quartile, hazard ratios (HR) associated with the second, third, and the shortest quartile were 0.91 [95% confidence interval (95% CI): 0.62-1.34], 1.11 (95% CI: 0.77-1.60), and 0.93 (95% CI: 0.64-1.35), respectively. Subgroup analyses by menopausal status, invasiveness, or estrogen receptor status of breast cancer did not reveal evidence of association between telomere length in blood cells and subsequent breast cancer risk. CONCLUSIONS: This prospective investigation does not support telomere length in blood cells as a biomarker for breast cancer risk.
OBJECTIVE: Telomeres are required for maintaining genomic integrity and may play a role in carcinogenesis. Some, but not all, epidemiologic studies have found that short telomeres in leukocytes are associated with an increased risk of breast cancer. To further elucidate this potential association, we examined telomere length in relation to breast cancer risk in prospectively collected blood samples from the Sister Study, a cohort of women aged 35-74 years who have a sister with breast cancer. METHODS: We performed a case-cohort analysis comparing incident breast cancer cases (n = 342) with a subcohort (n = 735), randomly selected from 29,026 participants, enrolled by June 1, 2007. Relative telomere length in peripheral blood cells was estimated using a single-tube monochrome multiplex quantitative PCR assay. RESULTS: No association was observed between telomere length and breast cancer risk. Compared with the longest quartile, hazard ratios (HR) associated with the second, third, and the shortest quartile were 0.91 [95% confidence interval (95% CI): 0.62-1.34], 1.11 (95% CI: 0.77-1.60), and 0.93 (95% CI: 0.64-1.35), respectively. Subgroup analyses by menopausal status, invasiveness, or estrogen receptor status of breast cancer did not reveal evidence of association between telomere length in blood cells and subsequent breast cancer risk. CONCLUSIONS: This prospective investigation does not support telomere length in blood cells as a biomarker for breast cancer risk.
Authors: A M Valdes; T Andrew; J P Gardner; M Kimura; E Oelsner; L F Cherkas; A Aviv; T D Spector Journal: Lancet Date: 2005 Aug 20-26 Impact factor: 79.321
Authors: Lisa Mirabello; Kai Yu; Peter Kraft; Immaculata De Vivo; David J Hunter; Jennifer Prescott; Jason Y Y Wong; Nilanjan Chatterjee; Richard B Hayes; Sharon A Savage Journal: Hum Mutat Date: 2010-09 Impact factor: 4.878
Authors: Koei Chin; Carlos Ortiz de Solorzano; David Knowles; Arthur Jones; William Chou; Enrique Garcia Rodriguez; Wen-Lin Kuo; Britt-Marie Ljung; Karen Chew; Kenneth Myambo; Monica Miranda; Sheryl Krig; James Garbe; Martha Stampfer; Paul Yaswen; Joe W Gray; Stephen J Lockett Journal: Nat Genet Date: 2004-08-08 Impact factor: 38.330
Authors: T Levy; I Agoulnik; E N Atkinson; X W Tong; H M Gause; A Hasenburg; I B Runnebaum; E Stickeler; V J Möbus; A L Kaplan; D G Kieback Journal: Anticancer Res Date: 1998 May-Jun Impact factor: 2.480
Authors: Jing Shen; Mary Beth Terry; Irina Gurvich; Yuyan Liao; Ruby T Senie; Regina M Santella Journal: Cancer Res Date: 2007-06-01 Impact factor: 12.701
Authors: Alan K Meeker; Jessica L Hicks; Edward Gabrielson; William M Strauss; Angelo M De Marzo; Pedram Argani Journal: Am J Pathol Date: 2004-03 Impact factor: 4.307
Authors: Marij Gielen; Geja J Hageman; Evangelia E Antoniou; Katarina Nordfjall; Massimo Mangino; Muthuswamy Balasubramanyam; Tim de Meyer; Audrey E Hendricks; Erik J Giltay; Steven C Hunt; Jennifer A Nettleton; Klelia D Salpea; Vanessa A Diaz; Ramin Farzaneh-Far; Gil Atzmon; Sarah E Harris; Lifang Hou; David Gilley; Iiris Hovatta; Jeremy D Kark; Hisham Nassar; David J Kurz; Karen A Mather; Peter Willeit; Yun-Ling Zheng; Sofia Pavanello; Ellen W Demerath; Line Rode; Daniel Bunout; Andrew Steptoe; Lisa Boardman; Amelia Marti; Belinda Needham; Wei Zheng; Rosalind Ramsey-Goldman; Andrew J Pellatt; Jaakko Kaprio; Jonathan N Hofmann; Christian Gieger; Giuseppe Paolisso; Jacob B H Hjelmborg; Lisa Mirabello; Teresa Seeman; Jason Wong; Pim van der Harst; Linda Broer; Florian Kronenberg; Barbara Kollerits; Timo Strandberg; Dan T A Eisenberg; Catherine Duggan; Josine E Verhoeven; Roxanne Schaakxs; Raffaela Zannolli; Rosana M R Dos Reis; Fadi J Charchar; Maciej Tomaszewski; Ute Mons; Ilja Demuth; Andrea Elena Iglesias Molli; Guo Cheng; Dmytro Krasnienkov; Bianca D'Antono; Marek Kasielski; Barry J McDonnell; Richard Paul Ebstein; Kristina Sundquist; Guillaume Pare; Michael Chong; Maurice P Zeegers Journal: Am J Clin Nutr Date: 2018-09-01 Impact factor: 7.045
Authors: Andrew J Pellatt; Roger K Wolff; Gabriela Torres-Mejia; Esther M John; Jennifer S Herrick; Abbie Lundgreen; Kathy B Baumgartner; Anna R Giuliano; Lisa M Hines; Laura Fejerman; Richard Cawthon; Martha L Slattery Journal: Genes Chromosomes Cancer Date: 2013-04-30 Impact factor: 5.006
Authors: Jacob K Kresovich; Zongli Xu; Katie M O'Brien; Clarice R Weinberg; Dale P Sandler; Jack A Taylor Journal: J Natl Cancer Inst Date: 2019-10-01 Impact factor: 13.506
Authors: Nicole M Niehoff; Hazel B Nichols; Alexandra J White; Christine G Parks; Aimee A D'Aloisio; Dale P Sandler Journal: Epidemiology Date: 2016-05 Impact factor: 4.822